The Use of Carbonic Anhydrase Inhibitors in Ophthalmology and Clinical Medicineab
- 1 June 1984
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 429 (1) , 609-619
- https://doi.org/10.1111/j.1749-6632.1984.tb12398.x
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretionExperimental Eye Research, 1983
- MONITORING ACETAZOLAMIDE TREATMENTActa Ophthalmologica, 1982
- The importance of carbonic anhydrase B and C for the unloading of CO2 by the human erythrocyteActa Physiologica Scandinavica, 1981
- Acetazolamide Dosage Forms in the Treatment of GlaucomaArchives of Ophthalmology (1950), 1980
- A Repeated Dose-Response Study of Methazolamide in GlaucomaArchives of Ophthalmology (1950), 1978
- A quantitative analysis of CO2 transport at rest and during maximal exerciseRespiration Physiology, 1978
- Renal Carbonic Anhydrase and the Pharmacology of Sulfonamide InhibitorsPublished by Springer Nature ,1969
- Advantages of Sustained-Release Therapy With Acetazolamide in Glaucoma*American Journal of Ophthalmology, 1963
- Local Action of the Carbonic Anhydrase Inhibitor, Acetazoleamide, on the Intraocular Pressure in Cats.Acta Pharmacologica et Toxicologica, 1957
- Decrease in Intraocular Pressure in Man by a Carbonic Anhydrase Inhibitor, Diamox*American Journal of Ophthalmology, 1954